Skip to main content
. 2021 Dec 2;12:787370. doi: 10.3389/fneur.2021.787370

Table 2.

Evidence, cerebral effects, and cognitive effects of treatment strategies to improve or slow cognitive decline in KFRT.

Evidence Summary of Cerebral findings Summary of cognitive effects
Lifestyle
Physical exercise (120, 138) Randomized controlled trials of cycling, treadmill and exercise classes over 3–12 months. Improved cerebral blood flow Improvements in executive function, memory, delayed recall and self-reported cognitive function.
Cognitive Training (120) Randomized trial data of intradialytic tablet-based games Not assessed Improvements in psychomotor speed and executive function
Medicinal
Supplements (130) Cross-over study of valerian supplementation on MMSE score and EEG findings, n = 39. No changes in EEG between groups Improved MMSE scores in those taking valerian
ESA to correct anemia (131, 139) Observational data. Use of ESA and effect on cerebral perfusion, oxygen consumption, event related potential and cognitive attention ESA improves cerebral perfusion and oxygen consumption. Electrophysiology parameters improved with greater Hct (mean 42.8 vs. 31.6%). Attention improved with higher Hct. The risk of ESA use overshadows potential benefit.
Kidney replacement therapy
Cooled dialysis (48) Randomized control trial data, n = 73. Measured brain diffusion parameters over 1 year in those receiving dialysis 0.5°C below body temperature. Diffusion markers stable in those with cooled dialysis. Cognitive function not assessed. Will be assessed in the pending e-CHECKED trial (122)
Renal transplantation (49, 50, 103) Observational data using cognitive assessment and cerebral imaging before and after transplantation. Improved diffusion parameters, normalization of neurotransmitters and neural networks as assessed by functional MRI. Improvements in general cognitive status, psychomotor speed, attention, memory, and abstract thinking have all been reported

MMSE, mini-mental state examination; EEG, electro-encephalogram; ESA, erythrocyte-stimulating agent; Hct, Hematocrit; e-CHECKED, Evaluation of the Effect of Cooled Hemodialysis on Cognitive Function in Patients Suffering With End-stage Kidney Disease; MRI, magnetic resonance imaging.